Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction
- PMID: 15492476
- DOI: 10.1291/hypres.27.563
Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction
Abstract
This study was performed to investigate the risk of cardiac events by eccentric or continuous dosing of nitrates in patients with healed myocardial infarction. A total of 573 patients with healed myocardial infarction were assigned to one of two groups: a nitrate-treatment (n =239) and a nontreatment (n =334) group. The nitrate-treatment group was further subdivided into a group receiving eccentric dosing of nitrates (n =153) and a group receiving continuous dosing of nitrates (n =86). The mean observation period was 11.2+/-8.2 months. The cardiac events investigated were nonfatal and fatal recurrent myocardial infarction, death from congestive heart failure, sudden death, worsening angina and rebound angina. Baseline characteristics were also compared among the three groups to determine any effects on outcome. Among the patients receiving eccentric or continuous dosing of nitrates, the rates of cardiac events were 12.7/1,000 person.year and 67.4/1,000 person.year, respectively, whereas the rate was 19.7/1,000 person.year in the nontreated patients. The incidence of cardiac events was significantly greater in patients receiving continuous dosing of nitrates than in the nontreated patients (p <0.05). Continuous dosing of nitrates thus increases cardiac events, and while eccentric dosing of nitrates does not increase them, it is also not effective at preventing them in patients with healed myocardial infarction.
Similar articles
-
Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.Jpn Circ J. 1996 Oct;60(10):779-88. doi: 10.1253/jcj.60.779. Jpn Circ J. 1996. PMID: 8933241 Clinical Trial.
-
Chronic use of continuous dosing of long-term nitrates does not prevent cardiac events in patients with severe acute myocardial infarction.Cardiology. 2000;94(3):139-45. doi: 10.1159/000047308. Cardiology. 2000. PMID: 11279318 Clinical Trial.
-
Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients.Angiology. 2002 Jul-Aug;53(4):399-408. doi: 10.1177/000331970205300405. Angiology. 2002. PMID: 12143944 Clinical Trial.
-
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.Cardiovasc Drugs Ther. 1997 Jan;10(6):735-42. doi: 10.1007/BF00053031. Cardiovasc Drugs Ther. 1997. PMID: 9110117 Review.
-
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.Drugs. 1987 Sep;34(3):391-403. doi: 10.2165/00003495-198734030-00005. Drugs. 1987. PMID: 3119308 Review.
Cited by
-
Stimulators and activators of soluble guanylate cyclase for urogenital disorders.Nat Rev Urol. 2018 Jan;15(1):42-54. doi: 10.1038/nrurol.2017.181. Epub 2017 Nov 14. Nat Rev Urol. 2018. PMID: 29133940 Review.
-
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates.Clin Res Cardiol. 2012 Jun;101(6):453-9. doi: 10.1007/s00392-012-0412-x. Clin Res Cardiol. 2012. PMID: 22298019 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical